In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels - PubMed (original) (raw)
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels
L J Suggs et al. J Biomed Mater Res. 1999 Jul.
Abstract
The in vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) [P(PF-co-EG)] hydrogels were assessed in order to investigate the influence of poly(ethylene glycol) molecular weight and copolymer composition. These materials have application as injectable cardiovascular implants; cytotoxicity due to leachable products, as well as inflammation caused by the biomaterial itself, may ultimately affect the biocompatibility of the implant. We utilized a 7-day in vitro cytotoxicity assay to quantify cell density and cellular proliferation in the presence of copolymer films. The copolymer films exhibited slight to moderate cytotoxicity toward cultured endothelial cells, showing 20-86% viability relative to controls. Cell viability increased with an increasing weight percent of PEG or, to a lesser extent, the molecular weight of PEG. In vivo biocompatibility was assessed using a cage implantation model over a 21-day time period. This system was used to characterize the local cellular and humoral inflammatory response in the surrounding exudate, as well as the size and density of macrophages adherent to the material itself. All copolymer formulations exhibited excellent biocompatibility relative to controls with no significant differences in total leukocyte count among the different formulations. The in vivo inflammatory reaction displayed normal wound healing over 21 days as shown by a progressive decrease in both leukocyte concentration and enzymatic activity. The surface coverage of the copolymer films remained relatively constant from 7 to 21 days. There were no cells larger than 0.003 mm2, which was previously shown to be the threshold value for foreign-body giant cells. These data suggest that P(PF-co-EG) hydrogels have potential for use as injectable biomaterials.
Similar articles
- In vitro and in vivo degradation of poly(propylene fumarate-co-ethylene glycol) hydrogels.
Suggs LJ, Krishnan RS, Garcia CA, Peter SJ, Anderson JM, Mikos AG. Suggs LJ, et al. J Biomed Mater Res. 1998 Nov;42(2):312-20. doi: 10.1002/(sici)1097-4636(199811)42:2<312::aid-jbm17>3.0.co;2-k. J Biomed Mater Res. 1998. PMID: 9773828 - Preparation and characterization of poly(propylene fumarate-co-ethylene glycol) hydrogels.
Suggs LJ, Kao EY, Palombo LL, Krishnan RS, Widmer MS, Mikos AG. Suggs LJ, et al. J Biomater Sci Polym Ed. 1998;9(7):653-66. doi: 10.1163/156856298x00073. J Biomater Sci Polym Ed. 1998. PMID: 9686333 - Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer.
Suggs LJ, West JL, Mikos AG. Suggs LJ, et al. Biomaterials. 1999 Apr;20(7):683-90. doi: 10.1016/s0142-9612(98)00226-9. Biomaterials. 1999. PMID: 10208411 - Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications.
Alexander A, Ajazuddin, Khan J, Saraf S, Saraf S. Alexander A, et al. Eur J Pharm Biopharm. 2014 Nov;88(3):575-85. doi: 10.1016/j.ejpb.2014.07.005. Epub 2014 Aug 1. Eur J Pharm Biopharm. 2014. PMID: 25092423 Review. - Investigation of potential injectable polymeric biomaterials for bone regeneration.
Dreifke MB, Ebraheim NA, Jayasuriya AC. Dreifke MB, et al. J Biomed Mater Res A. 2013 Aug;101(8):2436-47. doi: 10.1002/jbm.a.34521. Epub 2013 Feb 11. J Biomed Mater Res A. 2013. PMID: 23401336 Free PMC article. Review.
Cited by
- Biocompatibility and osseointegration properties of a novel high strength and low modulus β- Ti10Mo6Zr4Sn3Nb alloy.
Liu J, Wang K, Li X, Zhang X, Gong X, Zhu Y, Ren Z, Zhang B, Cheng J. Liu J, et al. Front Bioeng Biotechnol. 2023 Feb 10;11:1127929. doi: 10.3389/fbioe.2023.1127929. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36865033 Free PMC article. - Basic Principles of Emulsion Templating and Its Use as an Emerging Manufacturing Method of Tissue Engineering Scaffolds.
Aldemir Dikici B, Claeyssens F. Aldemir Dikici B, et al. Front Bioeng Biotechnol. 2020 Aug 12;8:875. doi: 10.3389/fbioe.2020.00875. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32903473 Free PMC article. Review. - Highly enhanced compatibility of human brain vascular pericyte cells on monolayer graphene.
Kim J, Kim S, Jung W. Kim J, et al. Bioengineered. 2017 Jan 2;8(1):85-91. doi: 10.1080/21655979.2016.1227622. Epub 2016 Sep 30. Bioengineered. 2017. PMID: 27689961 Free PMC article. - In vitro cytocompatibility of one-dimensional and two-dimensional nanostructure-reinforced biodegradable polymeric nanocomposites.
Farshid B, Lalwani G, Sitharaman B. Farshid B, et al. J Biomed Mater Res A. 2015 Jul;103(7):2309-21. doi: 10.1002/jbm.a.35363. Epub 2014 Nov 19. J Biomed Mater Res A. 2015. PMID: 25367032 Free PMC article. - Graphene coatings for biomedical implants.
Podila R, Moore T, Alexis F, Rao A. Podila R, et al. J Vis Exp. 2013 Mar 1;(73):e50276. doi: 10.3791/50276. J Vis Exp. 2013. PMID: 23486380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources